AAPL343.58-4.14 (-1.19%) ▼|ABBV285.94+0.30 (+0.11%) ▲|ABT103.73+0.03 (+0.03%) ▲|ACN243.84-5.53 (-2.22%) ▼|ADBE254.51-9.31 (-3.53%) ▼|AMAT391.89+14.65 (+3.88%) ▲|AMD533.06+16.27 (+3.15%) ▲|AMGN441.29+2.03 (+0.46%) ▲|AMT189.23+0.26 (+0.14%) ▲|AMZN249.00+1.00 (+0.40%) ▲|AVGO331.01+9.33 (+2.90%) ▲|AXP313.88+0.66 (+0.21%) ▲|BA188.99+0.64 (+0.34%) ▲|BAC50.74+0.18 (+0.36%) ▲|BKNG151.78-4.05 (-2.60%) ▼|BLK1,131.27+13.02 (+1.16%) ▲|BMY61.31-0.17 (-0.28%) ▼|BNY147.57+2.93 (+2.03%) ▲|BRK-B545.93+3.74 (+0.69%) ▲|C121.64+1.02 (+0.85%) ▲|CAT695.62+10.25 (+1.50%) ▲|CL92.58-1.47 (-1.56%) ▼|CMCSA21.95-0.75 (-3.28%) ▼|COF202.91+1.57 (+0.78%) ▲|COP151.54+0.74 (+0.49%) ▲|COST1,000.76-2.56 (-0.26%) ▼|CRM244.61-3.96 (-1.59%) ▼|CSCO110.53+4.03 (+3.78%) ▲|CVS92.17-1.31 (-1.40%) ▼|CVX232.52-0.70 (-0.30%) ▼|DE639.90-6.26 (-0.97%) ▼|DHR231.88+1.38 (+0.60%) ▲|DIS110.22-2.30 (-2.04%) ▼|DUK124.33-0.65 (-0.52%) ▼|EMR162.18+0.59 (+0.36%) ▲|FDX301.02+2.30 (+0.77%) ▲|GD354.67+5.31 (+1.52%) ▲|GE286.40+0.76 (+0.27%) ▲|GEV857.99+42.99 (+5.27%) ▲|GILD158.38+2.34 (+1.50%) ▲|GM76.24+0.32 (+0.42%) ▲|GOOG314.78-2.50 (-0.79%) ▼|GOOGL317.99-2.22 (-0.69%) ▼|GS897.99+22.31 (+2.55%) ▲|HD316.90-2.93 (-0.92%) ▼|HON219.75-1.40 (-0.63%) ▼|IBM252.76-0.80 (-0.32%) ▼|INTC91.85+4.89 (+5.62%) ▲|INTU335.36-8.04 (-2.34%) ▼|ISRG448.02-4.27 (-0.94%) ▼|JNJ265.55+1.74 (+0.66%) ▲|JPM334.93+3.35 (+1.01%) ▲|KO92.57-0.14 (-0.15%) ▼|LIN510.18+1.35 (+0.27%) ▲|LLY1,280.34+6.88 (+0.54%) ▲|LMT631.11+26.93 (+4.46%) ▲|LOW196.94-1.74 (-0.88%) ▼|LRCX239.61+9.51 (+4.13%) ▲|MA614.10-9.51 (-1.52%) ▼|MCD249.22+0.76 (+0.31%) ▲|MDLZ62.71-1.10 (-1.72%) ▼|MDT94.30-1.11 (-1.16%) ▼|META635.86-6.76 (-1.05%) ▼|MMM172.44-1.02 (-0.59%) ▼|MO73.56-0.76 (-1.02%) ▼|MRK140.96-4.32 (-2.97%) ▼|MS185.38+5.89 (+3.28%) ▲|MSFT531.29+6.78 (+1.29%) ▲|MU914.17+36.62 (+4.17%) ▲|NEE82.14+0.04 (+0.04%) ▲|NFLX63.11-2.74 (-4.16%) ▼|NKE37.61+0.31 (+0.82%) ▲|NOW156.43-2.53 (-1.59%) ▼|NVDA216.26+5.30 (+2.51%) ▲|ORCL125.99-0.17 (-0.13%) ▼|PEP135.20-0.57 (-0.42%) ▼|PFE29.78-0.25 (-0.83%) ▼|PG159.00-2.02 (-1.25%) ▼|PLTR199.36+2.61 (+1.32%) ▲|PM201.78+2.31 (+1.16%) ▲|QCOM178.50+2.59 (+1.47%) ▲|RTX197.18+6.17 (+3.23%) ▲|SBUX102.05+1.25 (+1.24%) ▲|SCHW89.81-0.78 (-0.86%) ▼|SO92.36-0.53 (-0.57%) ▼|SPG212.39+0.76 (+0.36%) ▲|T20.74-0.19 (-0.91%) ▼|TMO680.03+6.21 (+0.92%) ▲|TMUS145.09-1.46 (-0.99%) ▼|TSLA395.16+22.94 (+6.16%) ▲|TXN296.43+11.74 (+4.12%) ▲|UBER65.95-0.76 (-1.13%) ▼|UNH410.05-8.04 (-1.92%) ▼|UNP295.11+2.24 (+0.76%) ▲|UPS100.14-0.92 (-0.91%) ▼|USB59.87+0.29 (+0.49%) ▲|V404.06-3.86 (-0.95%) ▼|VZ43.09-1.57 (-3.51%) ▼|WFC82.75+0.36 (+0.44%) ▲|WMT119.68-0.21 (-0.18%) ▼|XOM184.35+1.14 (+0.62%) ▲|AAPL343.58-4.14 (-1.19%) ▼|ABBV285.94+0.30 (+0.11%) ▲|ABT103.73+0.03 (+0.03%) ▲|ACN243.84-5.53 (-2.22%) ▼|ADBE254.51-9.31 (-3.53%) ▼|AMAT391.89+14.65 (+3.88%) ▲|AMD533.06+16.27 (+3.15%) ▲|AMGN441.29+2.03 (+0.46%) ▲|AMT189.23+0.26 (+0.14%) ▲|AMZN249.00+1.00 (+0.40%) ▲|AVGO331.01+9.33 (+2.90%) ▲|AXP313.88+0.66 (+0.21%) ▲|BA188.99+0.64 (+0.34%) ▲|BAC50.74+0.18 (+0.36%) ▲|BKNG151.78-4.05 (-2.60%) ▼|BLK1,131.27+13.02 (+1.16%) ▲|BMY61.31-0.17 (-0.28%) ▼|BNY147.57+2.93 (+2.03%) ▲|BRK-B545.93+3.74 (+0.69%) ▲|C121.64+1.02 (+0.85%) ▲|CAT695.62+10.25 (+1.50%) ▲|CL92.58-1.47 (-1.56%) ▼|CMCSA21.95-0.75 (-3.28%) ▼|COF202.91+1.57 (+0.78%) ▲|COP151.54+0.74 (+0.49%) ▲|COST1,000.76-2.56 (-0.26%) ▼|CRM244.61-3.96 (-1.59%) ▼|CSCO110.53+4.03 (+3.78%) ▲|CVS92.17-1.31 (-1.40%) ▼|CVX232.52-0.70 (-0.30%) ▼|DE639.90-6.26 (-0.97%) ▼|DHR231.88+1.38 (+0.60%) ▲|DIS110.22-2.30 (-2.04%) ▼|DUK124.33-0.65 (-0.52%) ▼|EMR162.18+0.59 (+0.36%) ▲|FDX301.02+2.30 (+0.77%) ▲|GD354.67+5.31 (+1.52%) ▲|GE286.40+0.76 (+0.27%) ▲|GEV857.99+42.99 (+5.27%) ▲|GILD158.38+2.34 (+1.50%) ▲|GM76.24+0.32 (+0.42%) ▲|GOOG314.78-2.50 (-0.79%) ▼|GOOGL317.99-2.22 (-0.69%) ▼|GS897.99+22.31 (+2.55%) ▲|HD316.90-2.93 (-0.92%) ▼|HON219.75-1.40 (-0.63%) ▼|IBM252.76-0.80 (-0.32%) ▼|INTC91.85+4.89 (+5.62%) ▲|INTU335.36-8.04 (-2.34%) ▼|ISRG448.02-4.27 (-0.94%) ▼|JNJ265.55+1.74 (+0.66%) ▲|JPM334.93+3.35 (+1.01%) ▲|KO92.57-0.14 (-0.15%) ▼|LIN510.18+1.35 (+0.27%) ▲|LLY1,280.34+6.88 (+0.54%) ▲|LMT631.11+26.93 (+4.46%) ▲|LOW196.94-1.74 (-0.88%) ▼|LRCX239.61+9.51 (+4.13%) ▲|MA614.10-9.51 (-1.52%) ▼|MCD249.22+0.76 (+0.31%) ▲|MDLZ62.71-1.10 (-1.72%) ▼|MDT94.30-1.11 (-1.16%) ▼|META635.86-6.76 (-1.05%) ▼|MMM172.44-1.02 (-0.59%) ▼|MO73.56-0.76 (-1.02%) ▼|MRK140.96-4.32 (-2.97%) ▼|MS185.38+5.89 (+3.28%) ▲|MSFT531.29+6.78 (+1.29%) ▲|MU914.17+36.62 (+4.17%) ▲|NEE82.14+0.04 (+0.04%) ▲|NFLX63.11-2.74 (-4.16%) ▼|NKE37.61+0.31 (+0.82%) ▲|NOW156.43-2.53 (-1.59%) ▼|NVDA216.26+5.30 (+2.51%) ▲|ORCL125.99-0.17 (-0.13%) ▼|PEP135.20-0.57 (-0.42%) ▼|PFE29.78-0.25 (-0.83%) ▼|PG159.00-2.02 (-1.25%) ▼|PLTR199.36+2.61 (+1.32%) ▲|PM201.78+2.31 (+1.16%) ▲|QCOM178.50+2.59 (+1.47%) ▲|RTX197.18+6.17 (+3.23%) ▲|SBUX102.05+1.25 (+1.24%) ▲|SCHW89.81-0.78 (-0.86%) ▼|SO92.36-0.53 (-0.57%) ▼|SPG212.39+0.76 (+0.36%) ▲|T20.74-0.19 (-0.91%) ▼|TMO680.03+6.21 (+0.92%) ▲|TMUS145.09-1.46 (-0.99%) ▼|TSLA395.16+22.94 (+6.16%) ▲|TXN296.43+11.74 (+4.12%) ▲|UBER65.95-0.76 (-1.13%) ▼|UNH410.05-8.04 (-1.92%) ▼|UNP295.11+2.24 (+0.76%) ▲|UPS100.14-0.92 (-0.91%) ▼|USB59.87+0.29 (+0.49%) ▲|V404.06-3.86 (-0.95%) ▼|VZ43.09-1.57 (-3.51%) ▼|WFC82.75+0.36 (+0.44%) ▲|WMT119.68-0.21 (-0.18%) ▼|XOM184.35+1.14 (+0.62%) ▲|
21.4 C
New York
Monday, October 26, 2026

Tag: patient

newsFORsourcecompanycontentinformation1releasesmarket

BDC Laboratories Partners with Newly Launched Dilawri Cardiovascular Institute to Advance Clinically Relevant Cardiovascular Device Testing

Strategic collaboration supports cutting-edge translational research, combining regulatory-grade bench testing with clinical insight to improve outcomes for patients. WHEAT RIDGE, Colo. and VANCOUVER, BC, Aug....

Lilly reports second-quarter 2025 financial results and raises guidance

Revenue in Q2 2025 increased 38% to $15.56 billion driven by volume growth from Zepbound and Mounjaro. Increased the midpoint of our 2025 full-year...

Aveanna Healthcare Holdings Announces Second Quarter Financial Results and Revised 2025 Outlook

ATLANTA, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced financial results for the three and six-month periods ended June 28, 2025.

Nuvalent Highlights Pipeline and Business Achievements, Reiterates Key Anticipated Milestones, and Reports Second Quarter 2025 Financial Results

Initiated rolling NDA submission for zidesamtinib for TKI pre-treated patients with advanced ROS1-positive NSCLC, with target completion in the third quarter of 2025 Initiated ALKAZAR...

TRACEABILITY, QUALITY, SAFETY: OVER A DECADE OF ANTARES VISION GROUP’S CONTRIBUTION TO THE AFRICAN PHARMACEUTICAL SECTOR

The Group's advanced technologies and made in Italy quality ensure compliance to global standards, supply chain integrity and patient safety across the continent. In...

Implantica announces second publication of groundbreaking 5-year results from the landmark RefluxStop® clinical study

VADUZ, Liechtenstein, Aug. 7, 2025 /PRNewswire/ -- Implantica AG (publ), a leading medtech company pioneering advanced implantable medical technologies, today announced the second peer-reviewed...

Intas Pharmaceuticals and Accord BioPharma Become One of the Largest Global Suppliers of Pegfilgrastim with Acquisition of UDENYCA®

AHMEDABAD, India, Aug. 7, 2025 /PRNewswire/ -- Intas Pharmaceuticals in collaboration with its global subsidiaries operating under the Accord brand, has solidified its position as...

HIMS Shares Decline Amid Lower Revenue Per Order For GLP-1 Following Novo Nordisk Collaboration Termination, Securities Class Action Pending — Hagens Berman

SAN FRANCISCO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- On August 5, 2025, investors in Hims & Hers Health (NYSE: HIMS) declined almost 11% in another sell-off after the company disclosed that it would lower revenue recognized per customer specific to its so-called personalized GLP-1 component, a medication the company compounds to treat weight loss.

XtalPi and DoveTree Announce Landmark $6 Billion AI Drug Discovery Collaboration

Strategic partnership leverages AI and robotics for novel therapeutics across oncology, immunology, inflammation, neurology, and metabolic diseases. CAMBRIDGE, Mass., Aug. 7, 2025 /PRNewswire/ -- XtalPi...

XtalPi and DoveTree Announce Landmark $6 Billion AI Drug Discovery Collaboration

Strategic partnership leverages AI and robotics for novel therapeutics across oncology, immunology, inflammation, neurology, and metabolic diseases. CAMBRIDGE, Mass., Aug. 6, 2025 /PRNewswire/ -- XtalPi...

eJoule Supplies Wyon Swiss Batteries High Performance Single Crystal Cathode Active Material

FREMONT, Calif. and APPENZELL STEINEGG, Switzerland, Aug. 6, 2025 /PRNewswire/ -- eJoule Inc has fulfilled a multi-ton bulk order of high performance doped and...

Urothelial Carcinoma Market Set to Expand During the Forecast Period (2025-2034) Amid Rising Incidence and Evolving Therapeutic Landscape | DelveInsight

The dynamics of the urothelial carcinoma market are anticipated to change due to the demand for innovative therapies, particularly in chemotherapy and immunotherapy, and...

Urothelial Carcinoma Market Set to Expand During the Forecast Period (2025-2034) Amid Rising Incidence and Evolving Therapeutic Landscape | DelveInsight

The dynamics of the urothelial carcinoma market are anticipated to change due to the demand for innovative therapies, particularly in chemotherapy and immunotherapy, and...

CLK Inhibitors Market Poised for Growth as Demand Rises in Oncology and Musculoskeletal Disorders | DelveInsight

The CLK inhibitors market is projected to expand in the coming years, driven by a rising incidence of cancer diagnoses, growing awareness of these...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPatient

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers